Browsing Tag
OSPREY
2 posts
Helen of Troy rejects $1.6bn takeover proposal from Empower Brands as shares surge 25%
Helen of Troy has rejected an unsolicited $37-per-share cash acquisition proposal from Empower Brands, a business jointly owned by Spectrum Brands and Oaktree Capital Management. With shares rising approximately 25% following the public disclosure, the dispute is shifting towards whether the company's recovery plan can deliver greater value than an immediate cash exit.
Stoke Therapeutics has enrolled its pivotal Dravet trial, but what must the August 3 call prove?
Stoke Therapeutics will discuss its second-quarter performance on August 3 after completing enrollment in the pivotal EMPEROR trial. Investors will be looking beyond quarterly revenue to assess spending, regulatory execution and preparations for a possible zorevunersen launch.